Physician profile
Jack Williams
NPI 1598738189
$3,745.73
in general payments reported to CMS, 2019-2025
17 companies · $421 in 2025
The $421 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $40.39 · 2021: $336 · 2022: $409 · 2023: $1,546 · 2024: $805 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,799 · Consulting Fee: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,798.52 |
| Consulting Fee | $974.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,692.55 | 2021-2025 | |
| Optinose US, INC. | $624.46 | 2019-2025 | |
| Glaxosmithkline, LLC. | $450.63 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $323.71 | 2022-2025 | Dupixent |
| Kaleo, INC. | $125.89 | 2019-2021 | |
| Medtronic, INC. | $120.80 | 2024 | Propel |
| Acclarent, INC | $85.88 | 2019 | |
| Aerin Medical INC. | $60.93 | 2024 | |
| Stryker Corporation | $54.11 | 2024 | Formula, Hipcheck, Iconix |
| Smith+Nephew, INC. | $46.40 | 2021 | |
| Hikma Pharmaceuticals USA | $46.21 | 2023-2025 | Ryaltris |
| Pfizer INC. | $24.38 | 2023 | |
| Alk-Abello, INC | $24.10 | 2021 | |
| Csl Behring | $20.34 | 2025 | Andembry |
| Arbor Pharmaceuticals, INC. | $17.47 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $15.95 | 2025 | Tezspire |
| Integra Lifesciences Corporation | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.